Enviomycin

Suppliers

Names

[ CAS No. ]:
33103-22-9

[ Name ]:
Enviomycin

[Synonym ]:
Tuberactinomycin N
Tuberactinomycin A
Tuberactinomycin
Viomycin,1-(L-threo-3,6-diamino-4-hydroxyhexanoic acid)
(3R,4R)-3,6-diamino-4-hydroxy-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-L-seryl->-L-seryl->-(Z)-2-amino-3-ureido-acryloyl->-(S)-amino-((R)-2-amino-1(3),4,5,6-tetrahydro-pyrimidin-4-yl)-acetyl-(1->N3)]
C25H43N13O11
1-(L-threo-3,6-Diamino-4-hydroxyhexanoic acid)viomycin
3,6-diamino-4-hydroxy-hexanoyl->-cyclo-[L-2,3-diamino-propionyl->-L-seryl->-L-seryl->-2-amino-3-ureido-acryloyl->-(S)-amino-((4R)-2-amino-6t-hydroxy-1(3),4,5,6-tetrahydro-pyrimidin-4r-yl)-acetyl-(1->N3)]

Chemical & Physical Properties

[ Density]:
1.8g/cm3

[ Molecular Formula ]:
C25H43N13O10

[ Molecular Weight ]:
685.69000

[ Exact Mass ]:
685.32600

[ PSA ]:
412.29000

[ Index of Refraction ]:
1.762

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ZA3930000
CHEMICAL NAME :
Viomycin, 1-(threo-4-hydroxy-L-3,6-diaminohexanoic acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro- 4-pyrimidinyl)glycine)-, (R)-
CAS REGISTRY NUMBER :
33103-22-9
LAST UPDATED :
199506
DATA ITEMS CITED :
6
MOLECULAR FORMULA :
C25-H43-N13-O10
MOLECULAR WEIGHT :
685.81

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 6,530,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
640 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 6,530,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 6,530,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 6,530,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
370 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 6,530,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 6,530,1975

Related Compounds

  • Potassium tetracyanopalladate(II) xhydrate
  • 2-Allyl-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione
  • 2-(4-Benzylpiperazin-1-yl)-1-phenylethanone;hydrobromide
  • 3-Benzyloxyphenylboronic acid MIDA ester
  • 2-Methoxy-5-pyridinylboronicacidMIDAester
  • 2-(2-Methoxypyridin-3-yl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione
  • 4-hydroxy-3-[(4-hydroxy-2-oxo-3,4,4a,5,6,7,8,8a-octahydro-1H-quinolin-3-yl)-pyridin-3-ylmethyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-quinolin-2-one
  • 3-[[2-[[8-(3,5-Dihydroxyphenyl)-3,5,9-trimethyl-1,7-dioxaspiro[5.5]undec-2-yl]methyl]-1,2,4a,5,6,7,8,8a-octahydro-3,8-dimethyl-7-(sulfooxy)-1-naphthalenyl]carbonyl]-1,5-dihydro-4,5-dihydroxy-2H-pyrrol-2-one
  • 11-(4-Bromophenyl)-6-hydroxy-13-(trifluoromethyl)-8-thia-3,10-diazatricyclo[7.4.0.02,7]trideca-1(9),2,5,10,12-pentaen-4-one
  • 11-(4-Ethoxyphenyl)-6-hydroxy-13-(trifluoromethyl)-8-thia-3,10-diazatricyclo[7.4.0.02,7]trideca-1(9),2,5,10,12-pentaen-4-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.